Stock A185750 CHONG KUN DANG PHARMACEUTICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company Chong Kun Dang Pharmaceutical Corp.

Equities

A185750

KR7185750007

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-06 pm EDT 		5-day change 1st Jan Change
103,100 KRW +1.18% Intraday chart for Chong Kun Dang Pharmaceutical Corp. -1.15% -21.24%
Apr. 25 Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on January 23, 2024. CI
Jan. 23 Chong Kun Dang Pharmaceutical Corp. announces an Equity Buyback for KRW 15,000 million worth of its shares. CI

Business Summary

Chong Kun Dang Pharmaceutical Corp is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The company sells products in domestic and overseas markets.

Number of employees: 2,291

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
1,488,345 100.0 % 1,669,404 100.0 % +12.17%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
89.4 %
1,423,245 95.6 % 1,493,073 89.4 % +4.91%
Switzerland
6.4 %
-- 106,064 6.4 % -
Japan
2.5 %
45,891 3.1 % 41,157 2.5 % -10.32%
Others
1.7 %
8,626 0.6 % 29,110 1.7 % +237.46%

Managers

Managers TitleAgeSince
Young-Ju Kim CEO
 Chief Executive Officer 60 15-03-19
Jong-Rae Lim CTO
 Chief Tech/Sci/R&D Officer 57 -
Ja-Min Gu BRD
 Director/Board Member 60 -
Chang-Gyu Kim BRD
 Director/Board Member 68 -
Jong-Han Park PRN
 Corporate Officer/Principal 61 -
Ho-Seong Yoo PRN
 Corporate Officer/Principal 64 -
Yeo-Wook Go PRN
 Corporate Officer/Principal 61 -
Hong-Soon Park PRN
 Corporate Officer/Principal 68 -
Jong-Han Kang SAM
 Sales & Marketing 57 -
Dae-Gil Bae PRN
 Corporate Officer/Principal 61 -

Members of the board

Members of the board TitleAgeSince
Chang-Gyu Kim BRD
 Director/Board Member 68 -
Seong-Gon Kim BRD
 Director/Board Member 62 -
Ja-Min Gu BRD
 Director/Board Member 60 -
Young-Ju Kim CEO
 Chief Executive Officer 60 15-03-19
Ki-Won Kim BRD
 Director/Board Member 59 -
Soon-Wook Hong BRD
 Director/Board Member 68 19-03-14
In-Soo Kang BRD
 Director/Board Member 63 19-03-14
Dong-Shin Chang BRD
 Director/Board Member 55 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 13,174,420 6,908,366 ( 52.44 %) 471,810 ( 3.581 %) 52.44 %

Shareholders

NameEquities%Valuation
CHONG KUN DANG HOLDINGS CORP.
25.44 %
3,352,101 25.44 % 274 M ₩
Jang-Han Lee
9.534 %
1,256,007 9.534 % 103 M ₩
National Pension Service of Korea
8.363 %
1,101,818 8.363 % 90 M ₩
Kochon Foundation
5.118 %
674,324 5.118 % 55 M ₩
CHONG KUN DANG PHARMACEUTICAL CORP.
2.892 %
381,024 2.892 % 31 M ₩
Joo-won Rhee
1.481 %
195,060 1.481 % 16 M ₩
Joo-gyung Rhee
1.175 %
154,778 1.175 % 13 M ₩
Joo-ah Rhee
1.175 %
154,778 1.175 % 13 M ₩
AllianceBernstein Ltd.
0.1264 %
16,648 0.1264 % 1 M ₩
Wellington Management International Ltd.
0.0741 %
9,765 0.0741 % 799 334 ₩

Holdings

NameEquities%Valuation
CHONG KUN DANG PHARMACEUTICAL CORP.
2.89%
 381,024 2.89% 31,189,485 $

Company contact information

Chong Kun Dang Pharmaceutical Corp.

8 Chungjeong-ro Seondaemun-gu

03742, Seoul

+

http://www.ckdpharm.com
address Chong Kun Dang Pharmaceutical Corp.(A185750)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per region

Ratings for Chong Kun Dang Pharmaceutical Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
CHONG KUN DANG PHARMACEUTICAL CORP. Stock Chong Kun Dang Pharmaceutical Corp.
-21.24% 969M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.83% 43.57B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.70% 22.7B
SANDOZ GROUP AG Stock Sandoz Group AG
+17.22% 14.32B
CIPLA LIMITED Stock Cipla Limited
+11.11% 13.42B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+45.91% 11.83B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.84% 6.98B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.33% 5.51B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A185750 Stock
  4. Company Chong Kun Dang Pharmaceutical Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW